Tag Archives: AEHR

Top 10 High Tech Stocks To Watch Right Now

The upcoming Ryzen launch has propelled Advanced Micro Devices, Inc. stock near to its 10-year high. Can AMD stock gain further?
Flickr

Shares of Sunnyvale, California-based Advanced Micro Devices Inc (NASDAQ:AMD) are showing no signs of slowing down anytime soon, gaining more than 27% YTD after rising almost 296% in 2016. Of late AMD stock has been up due to the positive initial response to Ryzen CPUs and its official release date getting closer. We already discussed how AMD stock could head higher going into AMD Vega GPU preview. With AMD stock approaching its 10 year high, investors could feel the stock has run up too high. Investors would be wary of buying AMD stock at these levels with technicals also suggesting the stock has entered the overbought zone. However, AMD stock may still defy all odds and could be heading for much higher grounds. AMD stock, which was primarily driven by investor speculation in the past could see the speculations actually turning into reality in the coming days. The question now is, should you buy AMD stock near its 10-year high price?

Top 10 High Tech Stocks To Watch Right Now: Gilead Sciences, Inc.(GILD)

Advisors’ Opinion:

  • [By Cory Renauer]

    Intercept Pharmaceuticals Inc. (NASDAQ:ICPT), Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL), and Gilead Sciences Inc. (NASDAQ:GILD) are three top stocks for investing this arena, which could be worth as much as $35 billion annually by 2020. There are plenty of companies with NASH candidates, but these three biotechs rise to the top of the list for some very different reasons.

  • [By Dan Caplinger]

    Stocks have done quite well so far this year, and much of the upward push has come from positive earnings results from the many companies that have already reported this season. This afternoon, investors will hear from two more key players — Alphabet (NASDAQ:GOOG) (NASDAQ:GOOGL) and Gilead Sciences (NASDAQ:GILD) — and what they have to say could have a dramatic impact on their entire industries and the stock market as a whole.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Gilead Sciences (GILD)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 High Tech Stocks To Watch Right Now: L Brands, Inc.(LB)

Advisors’ Opinion:

  • [By Billy Duberstein]

    L Brands (NYSE:LB) has had a difficult 2018. The stock of the owner of brands including iconic lingerie brand Victoria’s Secret and beauty retailer Bath & Body Works is down 43% for the year as of this writing, approaching 52-week lows after a weak first-quarter earnings report. The 2018 downturn has pushed the company’s forward price-to-earnings ratio to just over 10, and the company’s dividend yield up over 7.5%.

  • [By Paul Ausick]

    L Brands Inc. (NYSE: LB) traded down about 3.1% Wednesday to set a new 52-week low of $26.25 after closing at $27.09 on Tuesday. The stock’s 52-week high is $63.10. Volume was more than 20% higher than the daily average of around 5 million. The parent company of Victoria’s Secret and other specialty retailers had no specific news.

  • [By Logan Wallace]

    L Brands (NYSE:LB) had its target price decreased by MKM Partners to $38.00 in a research note published on Friday. MKM Partners currently has a neutral rating on the specialty retailer’s stock.

  • [By Dan Caplinger]

    Wall Street had another good session on Thursday, with further gains for major markets as benchmarks like the Russell 2000 index of small-cap stocks flirted with record highs. A favorable reading from the consumer price index showed only modest growth in prices, and the idea that inflation remains in check led market participants to believe that the Federal Reserve won’t have to speed up its efforts to return short-term interest rates to more normal levels. Yet even with the overall market picking up ground, some companies had bad news that weighed on their share prices. Booking Holdings (NASDAQ:BKNG), Exelixis (NASDAQ:EXEL), and L Brands (NYSE:LB) were among the worst performers on the day. Here’s why they did so poorly.

Top 10 High Tech Stocks To Watch Right Now: National Western Life Group, Inc.(NWLI)

Advisors’ Opinion:

  • [By Ethan Ryder]

    National Western Life Group (NASDAQ:NWLI) was downgraded by BidaskClub from a “sell” rating to a “strong sell” rating in a note issued to investors on Friday.

  • [By Stephan Byrd]

    Millennium Management LLC trimmed its holdings in shares of National Western Life Group Inc (NASDAQ:NWLI) by 64.1% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,115 shares of the financial services provider’s stock after selling 1,993 shares during the period. Millennium Management LLC’s holdings in National Western Life Group were worth $340,000 as of its most recent filing with the SEC.

  • [By Logan Wallace]

    National Western Life (NASDAQ: NWLI) and Brighthouse Financial (NASDAQ:BHF) are both finance companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, risk, profitability and dividends.

Top 10 High Tech Stocks To Watch Right Now: Aehr Test Systems(AEHR)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Aehr Test Systems (AEHR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Here are some of the news stories that may have impacted Accern Sentiment Analysis’s analysis:

    Get Aehr Test Systems alerts:

    Critical Comparison: Data I/O (DAIO) & Aehr Test Systems (AEHR) (americanbankingnews.com) Form 4 AEHR TEST SYSTEMS For: May 08 Filed by: HENDRICKSON DAVID S (streetinsider.com) Aehr Test Systems (AEHR) CTO David S. Hendrickson Sells 5,000 Shares (americanbankingnews.com) Teradyne (TER) versus Aehr Test Systems (AEHR) Head to Head Review (americanbankingnews.com) Insider Selling: Aehr Test Systems (AEHR) Insider Sells 20,000 Shares of Stock (americanbankingnews.com)

    AEHR remained flat at $$2.28 during trading hours on Monday. The company had a trading volume of 64,100 shares, compared to its average volume of 136,351. Aehr Test Systems has a 52 week low of $2.26 and a 52 week high of $2.28. The stock has a market cap of $50.06 million, a price-to-earnings ratio of -7.86 and a beta of 0.82. The company has a current ratio of 4.62, a quick ratio of 3.20 and a debt-to-equity ratio of 0.33.

  • [By Logan Wallace]

    Aehr Test Systems (NASDAQ:AEHR) insider David S. Hendrickson sold 5,000 shares of the stock in a transaction dated Tuesday, May 22nd. The shares were sold at an average price of $2.37, for a total transaction of $11,850.00. Following the completion of the sale, the insider now owns 25,351 shares of the company’s stock, valued at approximately $60,081.87. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Top 10 High Tech Stocks To Watch Right Now: Corning Incorporated(GLW)

Advisors’ Opinion:

  • [By Matthew Cochrane]

    Shareholders cheered when Corning Inc (NYSE:GLW) reported its second-quarter earnings last month. After the share price declined by double-digit percentage points earlier this year when the company posted what was perceived to be a disappointing first quarter, the stock price has rebounded sharply and is now up more than 10% since its second-quarter results were released.

  • [By Steve Symington]

    Corning Incorporated (NYSE:GLW) released solid first-quarter 2018 results on Tuesday morning. The glass technologist met or exceeded expectations in each of its five business segments, and it clarified its growth targets both for the coming year and longer term.

  • [By Ethan Ryder]

    Fox Run Management L.L.C. cut its stake in shares of Corning Incorporated (NYSE:GLW) by 46.0% in the second quarter, HoldingsChannel.com reports. The firm owned 20,694 shares of the electronics maker’s stock after selling 17,620 shares during the quarter. Fox Run Management L.L.C.’s holdings in Corning were worth $569,000 at the end of the most recent quarter.

  • [By Joseph Griffin]

    Corning Incorporated (NYSE:GLW)’s share price reached a new 52-week high during trading on Thursday after Argus raised their price target on the stock from $36.00 to $42.00. Argus currently has a positive rating on the stock. Corning traded as high as $36.07 and last traded at $36.26, with a volume of 359595 shares changing hands. The stock had previously closed at $35.45.

Top 10 High Tech Stocks To Watch Right Now: Dominion Resources, Inc.(D)

Advisors’ Opinion:

  • [By Shane Hupp]

    Wealthcare Advisory Partners LLC trimmed its stake in Dominion Energy Inc (NYSE:D) by 8.4% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,193 shares of the utilities provider’s stock after selling 1,031 shares during the period. Wealthcare Advisory Partners LLC’s holdings in Dominion Energy were worth $755,000 at the end of the most recent reporting period.

  • [By ]

    Dominion Energy (NYSE: D) announced in March the first LNG shipment out of its Cove Point terminal in Maryland. The facility is only the second LNG export terminal to open in the continental United States and complements the company’s natural gas pipeline and storage assets.

  • [By Reuben Gregg Brewer]

    Larger utility Dominion Energy (NYSE:D) has leaped to the rescue, agreeing to acquire SCANA. However, it will walk away from the deal if its terms aren’t agreed to by regulators, specifically regarding the nuclear power mess. Moreover, because of the circumstances around the nuclear issue, it isn’t clear that regulators will approve the deal. At this point, there are two potential outcomes for dividend investors drawn to SCANA’s hefty 7% yield. The Dominion deal gets approved and the all-stock transaction reduces dividends received by SCANA shareholders by around 9%. Or, the deal fails and SCANA’s weak financial state leads to a dividend cut or, worse, a complete suspension.

  • [By ]

    Investors willing to invest in utilities have some options. They can buy one — or several — stocks of related companies, such as Dominion Energy (NYSE: D), for example.

  • [By Maxx Chatsko]

    Many major utilities are now ramping up investments in cost-saving, margin-boosting energy efficiency programs. In fact, there’s a strong correlation between the most ambitious renewable energy investment strategies and energy efficiency programs. Some utilities have a lot of catching up to do.  

    Xcel Energy (NASDAQ:XEL) has saved 13,000 GWh of electricity consumption across its network over the years, including 9,000 GWh since 2005. The company has an ambitious plan to retire coal-fired power plants and build new wind and solar power capacity, which, when coupled with energy efficiency, could allow it to generate 45% of its electricity from renewables in 2027. Additionally, fuel-related expenses would drop from 47% of capital investments in 2010 to just 28% in 2027. That would free up more cash flow for dividends or growth projects — or both. PG&E (NYSE:PCG) recently filed a plan to retire an aging fossil fuel power plant with distributed solar and energy efficiency programs, as discussed on a recent quarterly conference call with investors. The utility also offers some of the most ambitious customer rebates in the country, with up to $5,500 per household. Southern Company (NYSE:SO) has saved 2,700 GWh of electricity consumption across its network since 2000. By 2020, it will have invested $1 billion total in energy efficiency programs, although that lags well behind more ambitious peers. Dominion Energy (NYSE:D) was ranked second to last among all utilities in the country in energy efficiency by the American Council for an Energy Efficient Economy. That leaves plenty of room for improvement. A recent report suggests it’s possible to reduce new home energy consumption in Virginia (the company’s home state) by 60%, saving the utility billions in capital investments in the next decade by avoiding the need to build new facilities. Those efforts could also save customers $1.7 billion, but the utility’s most recent plan does not prioritize energy efficien

Top 10 High Tech Stocks To Watch Right Now: (SMPQY)

Advisors’ Opinion:

  • [By ]

    I studied the management running the company and found fantastic professionals coming from large institutions like Novartis AG (NYSE:NVS), Sun Pharmaceuticals Industries (OTCPK:SMPQY), AstraZeneca Group plc (NYSE:AZN), or Endo International plc (NASDAQ

Hot Undervalued Stocks To Buy For 2019

Introduction

Several articles appeared in SA noting that Commerzbank AG (OTCPK:CRZBY, the ADR) could be an interesting M&A candidate. We agree with such thesis. The bank is being dramatically undervalued by the market. It is trading at half of its book value per share. In addition, its cash per share is more than ten times its current share price.

Obviously, the political conditions in Europe and the interest rates in the Eurozone are not helping the bank. Additionally, we believe that the EU may not be much interested in seeing mergers between banks. As compared to the US, the financial sector is highly consolidated.

In this article, we will provide all the good and bad reasons for executing a corporate transaction. Furthermore, we will develop several case scenarios. We will also explain how will they affect the share price.

Financial Valuations and Bank Reaction

Before we proceed further, have a look at the most significant financial stats of Commerzbank (source):

Hot Undervalued Stocks To Buy For 2019: AbbVie Inc.(ABBV)

Advisors’ Opinion:

  • [By ]

    Booker’s report took on other companies as well. Pfizer (PFE) , Gilead Sciences (GILD) , AbbVie  (ABBV) , Amgen (AMGN) , Bristol-Myers Squibb (BMY) Eli Lilly & Co. (LLY) , and Mylan NV (MYL) are cited for everything from raising drug prices, to stock buybacks and putting shareholder interest before that of the public.

  • [By Chris Neiger, Anders Bylund, and Todd Campbell]

    To help you track down a few of these companies for your portfolio, we reached out to some Motley Fool contributors for dividend stock ideas. They came back with Uniti Group (NASDAQ:UNIT), AbbVie (NYSE:ABBV), and American Tower (NYSE:AMT). Here’s why.

  • [By Brian Feroldi, Keith Speights, and Sean Williams]

    So which stocks do our healthcare experts have their eye on right now? We asked these three Motley Fool investors to weigh in, and they pickedAbbVie (NYSE:ABBV),Cardinal Health (NYSE:CAH), and Masimo (NASDAQ:MASI).

  • [By George Budwell]

    After releasing downright worrisome first-quarter results, Gilead Sciences (NASDAQ:GILD) has seen its shares drop by a noteworthy 11.7% in the past few days. The big concern is that Gilead’s ailing hepatitis C franchise has yet to stabilize in the wake of newfound competition from AbbVie’s (NYSE:ABBV)Mavyret.

  • [By Keith Speights]

    AbbVie (NYSE:ABBV) ended 2017 with a bang, posting tremendousfourth-quarter results in January. The company has started 2018 with a bang, too.

    On Thursday, AbbVie announced its Q1 earnings results. Wall Street analysts thought the company would report revenue of $7.6 billion. AbbVie’s actual revenue total was $7.9 billion. Analysts expected adjusted earnings per share (EPS) of $1.79. AbbVie reported adjusted EPS in Q1 of $1.87.

  • [By ]

    In keeping with that philosophy, this week’s recommendation for my Income Trader subscribers was in AbbVie (NYSE: ABBV).

    Revisiting This Reliable Trade Target
    I’ve written about AbbVie a few times before. (So far, we’ve made trades on ABBV three times, and all three trades were winners.) It is one of the world’s largest drug makers (the seventh largest by market cap), known to many for its best-selling drug, Humira, a biologic therapy for autoimmune diseases including rheumatoid arthritis, Crohn’s disease and other inflammatory conditions. This is the best-selling drug in the world, with sales of more than $15 billion a year.

Hot Undervalued Stocks To Buy For 2019: ICON plc(ICLR)

Advisors’ Opinion:

  • [By Logan Wallace]

    Senomyx (NASDAQ: SNMX) and ICON (NASDAQ:ICLR) are both consumer staples companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, analyst recommendations, institutional ownership, dividends, profitability, earnings and risk.

Hot Undervalued Stocks To Buy For 2019: Aehr Test Systems(AEHR)

Advisors’ Opinion:

  • [By Max Byerly]

    Here are some of the news stories that may have impacted Accern Sentiment Analysis’s analysis:

    Get Aehr Test Systems alerts:

    Critical Comparison: Data I/O (DAIO) & Aehr Test Systems (AEHR) (americanbankingnews.com) Form 4 AEHR TEST SYSTEMS For: May 08 Filed by: HENDRICKSON DAVID S (streetinsider.com) Aehr Test Systems (AEHR) CTO David S. Hendrickson Sells 5,000 Shares (americanbankingnews.com) Teradyne (TER) versus Aehr Test Systems (AEHR) Head to Head Review (americanbankingnews.com) Insider Selling: Aehr Test Systems (AEHR) Insider Sells 20,000 Shares of Stock (americanbankingnews.com)

    AEHR remained flat at $$2.28 during trading hours on Monday. The company had a trading volume of 64,100 shares, compared to its average volume of 136,351. Aehr Test Systems has a 52 week low of $2.26 and a 52 week high of $2.28. The stock has a market cap of $50.06 million, a price-to-earnings ratio of -7.86 and a beta of 0.82. The company has a current ratio of 4.62, a quick ratio of 3.20 and a debt-to-equity ratio of 0.33.

Hot Undervalued Stocks To Buy For 2019: Express Scripts Holding Company(ESRX)

Advisors’ Opinion:

  • [By Cory Renauer]

    Regeneron’s cholesterol-lowering medication Praluent was another drug with multibillion-dollar potential that’s been a huge disappointment in the commercial setting. Trying to launch a treatment with a $14,000-per-year price tag didn’t work, but a more affordable solution is getting attention from the right people. Express Scripts (NASDAQ:ESRX), a pharmacy benefits manager with a national formulary that covers around 25 million Americans, recently agreed to a straightforward reimbursement path in return for drastically lowered pricing. Express Scripts also removed Praluent’s market rival Repatha from its formulary.

  • [By WWW.GURUFOCUS.COM]

    For the details of Jeff Ubben’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Jeff+Ubben

    These are the top 5 holdings of Jeff UbbenTwenty-First Century Fox Inc (FOX) – 53,326,334 shares, 18.41% of the total portfolio. Alliance Data Systems Corp (ADS) – 5,877,400 shares, 15.07% of the total portfolio. CBRE Group Inc (CBG) – 24,916,923 shares, 10.92% of the total portfolio. Shares reduced by 13.72%KKR & Co LP (KKR) – 47,750,000 shares, 10.18% of the total portfolio. Shares added by 4.82%Morgan Stanley (MS) – 17,959,620 shares,

  • [By Cory Renauer]

    Sanofi took the assessment and started engaging end payers to see if any would offer easy reimbursement for a lower net price that reflects ICER’s assessment, and the industry listened. As of July 1, the partners will cut the net price of Praluent in return for straightforward access for around 25 million Americans covered by theExpress Scripts (NASDAQ:ESRX) national formulary. Thepharmacy benefits manager, and will also remove formulary access for its main competitor, Amgen’s (NASDAQ:AMGN) Repatha.

  • [By Alexander Bird]

    Both CVS Health Corp. (NYSE: CVS) and Cigna Corp. (NYSE: CI) sank 5% while Express Scripts Holding Co. (NASDAQ: ESRX), one of the primary providers of pharmacy benefits, dropped 9.7% in response to the disruptive impact the announced partnership could have on the industry. Altogether, the healthcare sector lost a combined $30 billion in market share in the first two hours of trading today.

  • [By Joseph Griffin]

    State of Wisconsin Investment Board boosted its stake in Express Scripts (NASDAQ:ESRX) by 25.1% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 1,092,444 shares of the company’s stock after acquiring an additional 218,855 shares during the quarter. State of Wisconsin Investment Board owned 0.19% of Express Scripts worth $75,466,000 as of its most recent filing with the SEC.

  • [By ]

    Larry Robbins and his Glenview Capital Management LLC said he is supportive of health insurance titan Cigna Corp.’s (CI) acquisition of Express Scripts Holdings Co. (ESRX) , the country’s largest benefits management group, in a deal announced in March worth $67 billion.

Hot Undervalued Stocks To Buy For 2019: New York REIT, Inc.(NYRT)

Advisors’ Opinion:

  • [By Max Byerly]

    New York REIT (NYSE:NYRT) reached a new 52-week high and low on Monday . The stock traded as low as $17.51 and last traded at $17.60, with a volume of 7341 shares traded. The stock had previously closed at $17.85.